These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support. Cies JJ, Moore WS, Nichols K, Knoderer CA, Carella DM, Chopra A. Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363 [Abstract] [Full Text] [Related]
4. Vancomycin population pharmacokinetics in neonates. de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN. Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244 [Abstract] [Full Text] [Related]
7. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation. Asbury WH, Darsey EH, Rose WB, Murphy JE, Buffington DE, Capers CC. Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127 [Abstract] [Full Text] [Related]
8. Vancomycin is commonly under-dosed in critically ill children and neonates. Sosnin N, Curtis N, Cranswick N, Chiletti R, Gwee A. Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957 [Abstract] [Full Text] [Related]
9. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations. Reilly AM, Ding MX, Rower JE, Kiser TH. J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089 [Abstract] [Full Text] [Related]
11. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients. Ringenberg T, Robinson C, Meyers R, Degnan L, Shah P, Siu A, Sturgill M. Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890 [Abstract] [Full Text] [Related]
12. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit. Irikura M, Fujiyama A, Saita F, Fukushima S, Kitaoka H, Fukuda T, Kawase A, Kondo Y, Ishitsuka Y, Kondo G, Maeda T, Yukawa E, Irie T. Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150 [Abstract] [Full Text] [Related]
13. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations. Mehrotra N, Tang L, Phelps SJ, Meibohm B. Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303 [Abstract] [Full Text] [Related]
14. Vancomycin pharmacokinetics and dosing in premature neonates. McDougal A, Ling EW, Levine M. Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683 [Abstract] [Full Text] [Related]
15. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study. Bhatt-Mehta V, Schumacher RE, Faix RG, Leady M, Brenner T. Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340 [Abstract] [Full Text] [Related]
16. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target. Bhongsatiern J, Stockmann C, Roberts JK, Yu T, Korgenski KE, Spigarelli MG, Desai PB, Sherwin CM. Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817 [Abstract] [Full Text] [Related]
18. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis. Abdel-Hady E, El Hamamsy M, Hedaya M, Awad H. J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719 [Abstract] [Full Text] [Related]
20. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates. Mulubwa M, Griesel HA, Mugabo P, Dippenaar R, van Wyk L. Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]